Transparency of clinical trials in pancreatic cancer: An analysis of availability of trial results from the ClinicalTrials.gov database.

ABSTRACT:

Background

Pancreatic cancer (PC) is a highly malignant tumor of the digestive system. As clinical trials involving PC are increasingly being conducted, the transparency of the generated data has become an important issue of concern. In other areas of medicine, clinical trial transparency presents a worrying state of affairs. However, at present, there has been no study examining the transparency of data derived from PC clinical trials.

Methods

A comprehensive search was conducted in the ClinicalTrial.gov database for clinical trials investigating pancreatic cancer as of June 2022. We examined the availability of clinical trial results and recorded the characteristics of the trials.

Results

A total of 856 trials were included in this study, of which 668 were completed

SUBMITTER: Huang RQ 

PROVIDER: S-EPMC9853913 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature